Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adeleye O Adeshakin

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 13, 2026
Dihydroartemisinin enhances NKG2D CAR-T cell therapy against solid tumors by inducing NKG2D ligands and remodeling the tumor microenvironmentMuhammad Auwal Saliu, Mansur Dabai Salisu, Rabiatu Bako Suleiman, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironmentAdeleye O Adeshakin, Hao Shi, S Scott Perry, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 13, 2026
Dihydroartemisinin enhances NKG2D CAR-T cell therapy against solid tumors by inducing NKG2D ligands and remodeling the tumor microenvironmentMuhammad Auwal Saliu, Mansur Dabai Salisu, Rabiatu Bako Suleiman, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironmentAdeleye O Adeshakin, Hao Shi, S Scott Perry, et al.
Pageof 2